Bovilis^® Bovipast RSP Questions and Answers

For the active immunisation of cattle against:

- Parainfluenza-3 virus, to reduce infection,

- Respiratory Syncytial virus, to reduce infection and clinical signs,

- Mannheimia haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6.

Cross-reactive immunity to the A6 serotype of Mannheimia haemolytica has been demonstrated in a challenge experiment under laboratory conditions after primary course of vaccination.

Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against Bovine Respiratory Syncytial virus and Parainfluenza-3 virus is at its highest level. The duration of protective immunity has not been established in challenge experiments.

The onset of immunity for Bovilis Bovipast RSP is 2 weeks following datasheet vaccination protocol.

Bovilis Bovipast RSP can be used during pregnancy and lactation.

Dose: 5 ml

Method of administration: Subcutaneous use. Injection into the side of the neck.

Basic immunisation: Animals from approximately 2 weeks of age should receive two vaccinations separated by an interval of approximately 4 weeks.

Booster doses: If booster doses are required, a single dose should be given approximately 2 weeks before each risk period (e.g. transport, introduction into a herd, change of housing).

The vaccine must be shaken well before use.

For vaccine administration, needles of 1.5 to 2.0 mm diameter and 10 to 18 mm long are recommended. The vaccine should be brought to room temperature prior to use and injected quickly.

Bovilis Bovipast RSP requires storage in a refrigerator between 2^oC and 8^oC. Protect from frost and light.

The withdrawal period following Bovilis Bovipast RSP is zero days.

The shelf life of Bovilis Bovipast RSP after first opening is 10 hours.

Yes, it is licensed for concurrent use with Bovilis IBR Marker Live in calves from 3 weeks of age.